By the conclusion of this activity, a majority of participants will demonstrate knowledge of the impact of a hospital-wide algorithm to guide clinicians on when to administer premedication to patients receiving blood product transfusions by achieving a passing score on the posttest.
Ashley Hole is program manager for evidence-based practice, Alexandra Budhai is an assistant attending physician in transfusion medicine, Kerry King is a nurse leader, and P. Dayand Borge Jr. is chief of transfusion medicine and cell therapy, all at Memorial Sloan Kettering Cancer Center in New York City. These relevant relationships have been mitigated through peer review. All other authors and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.
Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center s Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
Authors: Ashley Hole, DNP; Alexandra Budhai, MD; Kerry King, MSN, RN; P. Dayand Borge Jr., MD, PhD
